Celltrion Healthcare, Institutional Investors Net Sell 363,000 Shares Over Last 5 Days... Stock Price 100,700 KRW (+0.5%)

As of 11:32 AM on the 19th, Celltrion Healthcare is trading at 100,700 KRW, up 0.5% from the previous day. The trading volume is 818,246 shares, which is about 30.35% of the previous day's volume. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

On August 14, Samsung Securities researcher Seo Geun-hee announced a target price of 130,000 KRW for Celltrion Healthcare, stating, "Operating profit exceeded consensus by 30.7%. Despite COVID-19, profitability improved due to stable growth of European biosimilars compared to the previous quarter and strong sales of Truxima in the U.S., reflecting positive variable factors."

Over the past five days, individual investors have net purchased 362,243 shares of Celltrion Healthcare, while foreign investors and institutions have net sold 18,260 shares and 363,000 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.